| Linh Huynh, | |
|
720 N Denton Tap Rd Ste 150, Coppell, TX 75019-2162 | |
| (972) 415-1350 | |
| Not Available |
| Full Name | Linh Huynh |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 720 N Denton Tap Rd Ste 150, Coppell, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518178078 | NPI | - | NPPES |
| 09969 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | P0608 (Texas) | Primary |
| Entity Name | Legacy Urgent Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568622272 PECOS PAC ID: 3072679828 Enrollment ID: O20090304000140 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | Communitymed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821417072 PECOS PAC ID: 9830315126 Enrollment ID: O20140722002029 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | Communitymed Pcp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063818219 PECOS PAC ID: 7618295007 Enrollment ID: O20150415001009 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | El Dorado Urgent Care, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154799328 PECOS PAC ID: 0547528887 Enrollment ID: O20171214002627 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | Woodbridge Physicians Staffing Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750777322 PECOS PAC ID: 1052679305 Enrollment ID: O20171214002834 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | Unity Coppell |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063196889 PECOS PAC ID: 8022466960 Enrollment ID: O20231202000529 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Entity Name | Unity Medical Investments Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225818867 PECOS PAC ID: 9931557873 Enrollment ID: O20240228000369 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linh Huynh, 720 N Denton Tap Rd Ste 150, Coppell, TX 75019-2162 Ph: (469) 833-2675 | Linh Huynh, 720 N Denton Tap Rd Ste 150, Coppell, TX 75019-2162 Ph: (972) 415-1350 |
News Archive
GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.
Scientists who study a molecule known to play a role in certain types of cancers and neurodegenerative disorders have a powerful new tool to study this compound due to research conducted at Indiana University.
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.
Seeking to bring clarity to the debate on mobile phone use, researchers from the University of Essex have published the results of an investigation into the effects of mobiles on attention.
› Verified 4 days ago
Laura Golightly, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 601 Canyon Drive Suite 100, Coppell, TX 75019 Phone: 972-745-7500 Fax: 972-471-0700 | |
Jyoti Bharti, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Plaza Blvd, Coppell, TX 75019 Phone: 972-906-9130 | |
Guadalupe Reyna, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2999 Olympus Blvd Ste 300, Coppell, TX 75019 Phone: 214-645-6800 | |
Dr. Marc Anduss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 645 E State Highway 121, Coppell, TX 75019 Phone: 972-745-7500 Fax: 972-745-4336 | |
Dr. Nina Gale Cahan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 848 S Denton Tap Rd, 100, Coppell, TX 75019 Phone: 972-393-5559 Fax: 972-393-5479 | |
Dr. Crystal Renee Foster, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2999 Olympus Blvd Ste 300, Coppell, TX 75019 Phone: 214-645-6800 | |
Diana Coxsey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 580 S Denton Tap Rd, #123, Coppell, TX 75019 Phone: 972-462-0762 Fax: 972-393-2133 |